<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: Re: Protein antifreeze</TITLE>
<META NAME="Author" CONTENT="Doug Jones (random@qnet.com)">
<META NAME="Subject" CONTENT="Re: Protein antifreeze">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>Re: Protein antifreeze</H1>
<!-- received="Sat Jan 15 20:37:33 2000" -->
<!-- isoreceived="20000116033733" -->
<!-- sent="Sat, 15 Jan 2000 19:37:30 -0800" -->
<!-- isosent="20000116033730" -->
<!-- name="Doug Jones" -->
<!-- email="random@qnet.com" -->
<!-- subject="Re: Protein antifreeze" -->
<!-- id="38813CFA.FED1B8F1@qnet.com" -->
<!-- inreplyto="3.0.6.32.20000115174841.007b9b90@coastside.net" -->
<STRONG>From:</STRONG> Doug Jones (<A HREF="mailto:random@qnet.com?Subject=Re:%20Protein%20antifreeze&In-Reply-To=&lt;38813CFA.FED1B8F1@qnet.com&gt;"><EM>random@qnet.com</EM></A>)<BR>
<STRONG>Date:</STRONG> Sat Jan 15 2000 - 20:37:30 MST
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="0787.html">Eliezer S. Yudkowsky: "Pleconaril"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0785.html">Technotranscendence: "Re: BBC Polemics: Help needed!"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="0782.html">Jeff Davis: "Re: Protein antifreeze"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0797.html">CurtAdams@aol.com: "Re: Protein antifreeze"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#786">[ date ]</A>
<A HREF="index.html#786">[ thread ]</A>
<A HREF="subject.html#786">[ subject ]</A>
<A HREF="author.html#786">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
Jeff Davis wrote:
<BR>
<EM>&gt; &gt;TAPET® (Tumor Amplified Protein Expression Therapy), Vion's core platform
</EM><BR>
<EM>&gt; &gt;technology, are highly attenuated bacteria that, in preclinical
</EM><BR>
<EM>&gt; &gt;studies, have demonstrated preferential replication in tumors compared to
</EM><BR>
<EM>&gt; &gt;normal tissues.
</EM><BR>
<P>&lt;chuckle&gt; So they're breeding bugs that go, &quot;Mmmmm, cancer cells, yum!&quot;  I
<BR>
*like* it...
<BR>
<P>Set a thief to catch a thief, sorta.  I suppose they found the preferential
<BR>
replication in tumors by a selective breeding technique (variation and
<BR>
selection), but added the chemotherapy genes directly.  Best of both
<BR>
worlds- elegant!
<BR>
<P>Those bugs will be *damn* hard to maintain at a good level of preparedness,
<BR>
unless expression of the tumor killing protein can be switched on &amp; off by
<BR>
a separate chemical signal.  Without this, the in vitrio cell growth setup
<BR>
would kill the host tumor cells before a large batch of bacteria could be
<BR>
grown.
<BR>
<P><PRE>
--
Doug Jones
Rocket Plumber, XCOR Aerospace
<A HREF="http://www.xcor-aerospace.com">http://www.xcor-aerospace.com</A>
</PRE>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="0787.html">Eliezer S. Yudkowsky: "Pleconaril"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0785.html">Technotranscendence: "Re: BBC Polemics: Help needed!"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="0782.html">Jeff Davis: "Re: Protein antifreeze"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0797.html">CurtAdams@aol.com: "Re: Protein antifreeze"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#786">[ date ]</A>
<A HREF="index.html#786">[ thread ]</A>
<A HREF="subject.html#786">[ subject ]</A>
<A HREF="author.html#786">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Thu Jul 27 2000 - 14:02:18 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
